Assisting women to make informed choices about screening for Group B Streptococcus in pregnancy: A critical review of the evidence

Sheehy, A; Davis, D; Homer, CSE

Assisting women to make informed choices about screening for Group B Streptococcus in pregnancy: A critical review of the evidence

Sheehy, A

Davis, D

Homer, CSE

Permalink

Publication Type:: Journal Article
Citation:: Women and Birth, 2013, 26 (2), pp. 152 - 157
Issue Date:: 2013-06-01

Closed Access

	Filename	Description	Size
	2012002617OK.pdf		264.03 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Sheehy, A https://orcid.org/0000-0002-0037-1501	en_US
dc.contributor.author	Davis, D https://orcid.org/0000-0002-2041-1064	en_US
dc.contributor.author	Homer, CSE https://orcid.org/0000-0002-7454-3011	en_US
dc.date.available	2012-10-17	en_US
dc.date.issued	2013-06-01	en_US
dc.identifier.citation	Women and Birth, 2013, 26 (2), pp. 152 - 157	en_US
dc.identifier.issn	1871-5192	en_US
dc.identifier.uri	http://hdl.handle.net/10453/27622
dc.description.abstract	The approach to the prevention of early onset GBS disease in the newborn varies considerably from country to country. The Centre for Disease Control in the United States advocates universal culture based screening with the administration of intra-partum antibiotics, usually benzylpenicillin or ampicillin, to women who are colonised with GBS. National groups in the UK and New Zealand advocate a risk-based approach where intra-partum antibiotics are given to women with identified risk factors. The Canadian Taskforce on preventive health care has identified a third approach; where intra-partum antibiotics are given to women with a positive GBS culture and an identified risk factor. There are no national guidelines or consensus in Australia. The aim of this paper is to explore the evidence for screening and intrapartum prophylaxis for GBS. The three main methods of detection and management of GBS in pregnancy are described and the implications for women and midwifery practice are addressed. It is hoped that this discussion will provide women, midwives and other clinicians with a summary of the evidence, risks and benefits to enable informed decision making. © 2012 Australian College of Midwives.	en_US
dc.relation.ispartof	Women and Birth	en_US
dc.relation.isbasedon	10.1016/j.wombi.2012.10.004	en_US
dc.subject.classification	Obstetrics & Reproductive Medicine	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Streptococcus agalactiae	en_US
dc.subject.mesh	Streptococcal Infections	en_US
dc.subject.mesh	Pregnancy Complications, Infectious	en_US
dc.subject.mesh	Anti-Bacterial Agents	en_US
dc.subject.mesh	Prenatal Diagnosis	en_US
dc.subject.mesh	Mass Screening	en_US
dc.subject.mesh	Antibiotic Prophylaxis	en_US
dc.subject.mesh	Population Surveillance	en_US
dc.subject.mesh	Risk Factors	en_US
dc.subject.mesh	Decision Making	en_US
dc.subject.mesh	Pregnancy	en_US
dc.subject.mesh	Infant, Newborn	en_US
dc.subject.mesh	Australia	en_US
dc.subject.mesh	Female	en_US
dc.subject.mesh	Infectious Disease Transmission, Vertical	en_US
dc.title	Assisting women to make informed choices about screening for Group B Streptococcus in pregnancy: A critical review of the evidence	en_US
dc.type	Journal Article
utslib.citation.volume	2	en_US
utslib.citation.volume	26	en_US
utslib.for	1110 Nursing	en_US
utslib.for	11 Medical and Health Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
pubs.organisational-group	/University of Technology Sydney/Strength - WHO CC
pubs.organisational-group	/University of Technology Sydney/Students
utslib.copyright.status	closed_access
pubs.issue	2	en_US
pubs.publication-status	Published	en_US
pubs.volume	26	en_US

Abstract:

The approach to the prevention of early onset GBS disease in the newborn varies considerably from country to country. The Centre for Disease Control in the United States advocates universal culture based screening with the administration of intra-partum antibiotics, usually benzylpenicillin or ampicillin, to women who are colonised with GBS. National groups in the UK and New Zealand advocate a risk-based approach where intra-partum antibiotics are given to women with identified risk factors. The Canadian Taskforce on preventive health care has identified a third approach; where intra-partum antibiotics are given to women with a positive GBS culture and an identified risk factor. There are no national guidelines or consensus in Australia. The aim of this paper is to explore the evidence for screening and intrapartum prophylaxis for GBS. The three main methods of detection and management of GBS in pregnancy are described and the implications for women and midwifery practice are addressed. It is hoped that this discussion will provide women, midwives and other clinicians with a summary of the evidence, risks and benefits to enable informed decision making. © 2012 Australian College of Midwives.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/27622